Branch vs. Central Retinal Artery Occlusion: Is a Branch Occlusion Still an Emergency?
Warning Signs That Mean You Need Care Today
The word branch sounds small. Your eye doctor does not treat it that way. If you have sudden, painless vision loss in all or part of one eye, go to a hospital emergency department or your ophthalmologist right away1. Do not wait to see if it clears on its own. Go right away for any of these:
- Sudden vision loss in one eye, whole or partial.
- A gray curtain or a shadow across part of your sight.
- A new blank or dim patch that does not clear when you blink.
- New floaters, or flashing lights, in one eye.
- Sudden double vision, weakness on one side, or slurred speech. Call 911 for these.
Most sudden blur turns out to be minor. A blocked retinal artery is not common. But the clock is short, so your team must check fast. A same day visit costs you an afternoon. Waiting can cost sight, and it can miss a stroke.
Both blockages are the same event in a different pipe. A retinal artery occlusion means blood flow to the retina is blocked. A central one blocks the central artery of the retina and can cause immediate painless vision loss. A branch one blocks a smaller retinal artery, and in some cases causes no symptoms at all1. The American Academy of Ophthalmology advises immediate referral to the nearest stroke referral center for an acute occlusion that caused symptoms, and it notes that a branch occlusion, less commonly than a central one, can still be linked to life threatening conditions such as carotid artery disease or heart valve disease2. The size of the blind spot does not measure the danger.
Two situations look alike and are handled differently. For an acute occlusion that caused symptoms, the Academy advises immediate referral to the nearest stroke referral center. For one found by chance, with no symptoms, the right timing is unsettled, but a timely referral is still advised2. A small blind patch counts. So does a dim wedge, or a blackout that cleared. If you noticed anything in the last day or two, take the urgent path, and say so at the front desk.
Branch and Central Retinal Artery Occlusion at a Glance
Both usually begin far from the eye. A fragment of debris breaks loose from the neck arteries, the heart, or the aorta, then travels forward until a retinal vessel is too narrow to let it pass. The American Heart Association counts retinal infarction (clinical: tissue death from lost blood flow) as a form of acute ischemic stroke, notes that about 95 of every 100 central occlusions arise from clot and plaque disease, and calls for rapid triage to the nearest emergency department3. Wherever that debris came from, the source is still there until someone finds it.
The difference is where the debris stopped, not what it was made of. The central retinal artery is the main supply line into the inner retina, so a blockage there starves the whole inner layer at once. A branch is a tributary downstream, so a blockage there starves one wedge and leaves the rest fed. That is why reading vision often survives a branch occlusion. In 199 consecutive untreated patients with a branch occlusion, about 74 of every 100 eyes with a permanent blockage could read 20/40 or better at the first visit4. Good vision on the chart is a fact about your retina, not about your arteries.
Expect two tracks side by side. The eye track maps the damage with a dilated exam and scans. The body track hunts for the source. When a retinal embolus is found, the recommended evaluation includes carotid duplex ultrasound, an electrocardiogram to look for atrial fibrillation, echocardiography to identify a cardiac source, CT or MRI angiography of the neck vessels, and referral to primary care5. The body track is where most of the benefit sits, for either type.
What Each Type of Blockage Actually Is
The central retinal artery enters through the optic nerve and feeds the inner retina. When it blocks, sight in that eye usually drops suddenly and without pain. It is uncommon, and it becomes more common with age. In a nationwide study of nearly 50 million people in South Korea, central retinal artery occlusion occurred in about 2 of every 100,000 people per year, rising to about 12 of every 100,000 per year among people aged 80 to 846. Not every one is permanent. In a prospective series of 260 eyes, about 16 of every 100 central occlusions were brief and about 4 of every 100 came from arterial inflammation rather than debris7.
A branch occlusion blocks a smaller vessel, so the starved zone is a wedge rather than the whole inner retina. People describe a missing slice of field, a dim step when they cover the other eye, or nothing at all. It blocks the small arteries in the retina and in some instances causes no symptoms1. These are not a rare footnote. Of 131 people treated for a retinal artery occlusion at one center over a decade, 37 had a branch occlusion and 94 had a central occlusion8.
Most of these fragments are cholesterol. Hollenhorst plaques are microscopic cholesterol emboli in the retinal vessels that come from atherosclerotic plaque in larger arteries such as the carotid or the aorta, and about 80 of every 100 retinal emboli are of this cholesterol type5. A fragment that took a tributary today could take the main line, or a brain artery, next time. That is why the workup does not shrink when the label says branch.
Branch and Central Occlusion Side by Side
This is where the two genuinely differ. Fewer than 20 of every 100 people with a central occlusion regain useful sharpness in that eye3. Among permanent branch occlusions, vision of 20/40 or better rose from about 74 of every 100 eyes at the first visit to about 89 of every 100 later4.
| What is measured | Central occlusion | Branch occlusion |
|---|---|---|
| Area of retina starved | The whole inner retina of that eye | One wedge, fed by the blocked tributary |
| Usual effect on sight | Sudden painless loss across the eye | A missing slice of field; reading often intact |
| Reading vision at follow-up | Fewer than 20 of every 100 regain useful acuity | About 89 of every 100 permanent cases reach 20/40 or better |
| Chance of no symptoms at all | Unusual | Happens; some are found on a routine exam |
This is the column where they look alike, and it should drive your next week. Among 131 patients followed for up to 11 years, ischemic stroke occurred in about 11 of every 100 with a central occlusion and about 8 of every 100 with a branch occlusion (p=0.662), and the authors concluded that the outlook for stroke, heart attack and death was similar for both, so both warrant extended imaging and a systemic vascular risk assessment8.
| What is measured | Central occlusion | Branch occlusion |
|---|---|---|
| Fresh brain injury on early MRI | About 30 of every 100 | About 25 of every 100 |
| Stroke over long follow-up | About 11 of every 100 | About 8 of every 100, not a significant difference |
| Carotid plaque on imaging | About 91 of every 100 | About 72 of every 100 |
| Severe carotid narrowing (over 70 percent) | About 18 of every 100 | About 16 of every 100 |
| Workup advised | Full stroke and vascular workup | The same full workup |
If your sight dropped hard across the whole eye, you likely have a central occlusion. If you lost a slice, or nothing you noticed, you likely have a branch occlusion, and that conversation is usually kinder. Neither answer changes the body track. Ask which type you have, then ask the same questions either way: who is imaging my neck arteries, who is checking my heart rhythm, and when.
Why a Branch Occlusion Is Treated as an Emergency Anyway
Stroke is defined by where tissue dies, not by how much you noticed. The American Heart Association states that ischemic stroke is an episode of neurological dysfunction caused by focal infarction, that retinal infarction meets that definition, and that management starts with rapid triage to the nearest emergency department3. At the front desk, saying retinal artery occlusion, a form of stroke, moves you faster than describing a blurry patch.
This is the most direct answer to the branch question, and it comes from imaging rather than opinion. In pooled cohorts scanned by MRI within 7 days, fresh brain ischemia was present in about 30 of every 100 central occlusions and about 25 of every 100 branch occlusions, and much of it caused no neurological symptoms; the authors recommend prompt referral for neurological evaluation and brain imaging9. Your eye chart cannot see that. A scan can, and finding it changes which medicines you are offered.
One cause is inflammatory rather than embolic, and it can reach the second eye within days. In patients over 50, giant cell arteritis must be suspected, and urgent systemic corticosteroid therapy should be considered when it is diagnosed or very likely, to try to preserve or recover vision in the affected eye and to protect the other eye2. Mention any new headache, scalp tenderness, jaw ache when chewing, unexplained fever, or weight loss. Blood tests are usually ordered the same day. Treatment often starts while the testing is still running.
Risks, Outlook, and What the Numbers Really Say
Averages describe groups, and no one can promise your eye a result. The picture is encouraging for sharpness and mixed for the field. In the branch occlusion series, among eyes with abnormal fields, central field defects improved in about 47 of every 100 and peripheral defects in about 52 of every 1004. Read that as a gap that often softens, not one that reliably closes.
Here the honest answer is harder, and better said plainly. Fewer than 20 of every 100 people regain useful sharpness in the affected eye3. Among eyes seen within 7 days with counting fingers vision or worse, sight improved in about 22 of every 100 ordinary permanent cases and stayed the same in about 66 of every 100; in primate experiments the retina showed no detectable damage when circulation returned within 97 minutes, while about 240 minutes produced massive irreversible damage7. Animal timings do not transfer exactly to people, but they explain why the door closes in hours.
This is the number that should shape your next month, whichever type you have. Pooling 12 studies and 319,748 people, a retinal artery occlusion carried a stroke rate about 3.6 times that of comparison groups, and the risk clustered early: about 4 of every 100 people had a stroke within the first 30 days, falling to about 1 of every 200 between days 31 and 90, which led the authors to conclude that cerebrovascular evaluation and monitoring are needed within the first month10. That is a window, not a verdict. Most people in those studies did not have a stroke, and finishing the workup quickly is the most useful thing you can do.
A minority of eyes later grow fragile new vessels that raise eye pressure and threaten sight again. Patients with greater retinal ischemia require frequent follow-up, and panretinal photocoagulation is recommended for those who develop new vessels on the iris or retina2. So a red, painful eye with halos around lights is a same day call. Keeping your scheduled checks is what catches this early, while laser is still a straightforward fix.
When to Call, and Who Should Be on Your Team
Ask for a same day slot if any of these appear: a new or growing blind patch, a sudden drop in sharpness, a curtain or shadow across your sight, new floaters or flashing lights, or a red painful eye with halos around lights. Call 911 instead for weakness on one side, facial droop, trouble speaking, sudden severe headache, or sudden double vision. Those are brain stroke signs, and they run on an even shorter clock.
Your team usually has three parts: an eye doctor for the retina, a stroke or vascular service for the source, and primary care to hold the plan together. People with retinal cholesterol emboli had a higher rate of stroke than comparison groups, about 9 of every 100 against about 1 of every 100, which is why referral to primary care for a full vascular assessment is advised alongside the carotid and cardiac testing5. Before you leave, ask for your next visit date, and the name of whoever is booking the neck and heart tests. If a promised test is not scheduled within a week, chase it.
Common Questions About Branch and Central Retinal Artery Occlusion
If the change started in the last day or two, no. Treat it as urgent and say so. The Academy advises immediate referral to the nearest stroke referral center for an acute occlusion that caused symptoms, and a timely referral when one is found by chance without symptoms2. The visit is less about your eye than about finding the source of the debris before it travels somewhere worse. Asking for a same day slot is reasonable, and most clinics expect that call.
Yes, because the chart measures a patch of retina rather than your arteries. In pooled MRI cohorts scanned within 7 days, fresh brain ischemia was present in about 25 of every 100 branch occlusions, and much of that brain injury caused no neurological symptoms at all9. Silent findings still change your medicines and the urgency of neck artery treatment. Good vision is genuinely good news for your eye. It is not evidence about the rest of you.
For your eye, usually yes. For the rest of your body, not reliably. In 131 patients followed for up to 11 years, later stroke occurred in about 11 of every 100 central and about 8 of every 100 branch occlusions, heart attack in about 2 and about 3 of every 100, with no statistically significant differences, so the authors advised the same vascular assessment for both8. That study was small and from one center, so treat the gap as unproved rather than absent.
Sometimes it shrinks, often it partly stays, and no one can promise a result for one person. Among branch occlusion eyes with abnormal visual fields, central field defects improved in about 47 of every 100 and peripheral field defects improved in about 52 of every 1004. Ask for formal visual field testing rather than an eye chart alone, since the chart can look perfect while a wedge of field is missing. Repeat testing over a few months shows which way yours is going.
Expect a standard set, whichever type you have. The recommended evaluation after a retinal embolus includes carotid duplex ultrasound, an electrocardiogram to look for atrial fibrillation, echocardiography to look for a cardiac source, CT or MRI angiography of the neck vessels, and referral to primary care for a comprehensive vascular assessment5. Blood pressure, cholesterol and blood sugar are usually reviewed too. If you are over 50, blood tests for arterial inflammation are typically added.
More Questions People Ask Their Retina Specialist
Not a reliable one, and being told that early is better than false hope. After the acute phase there are no proven treatments to reverse the vision loss caused by a central, branch or ophthalmic artery occlusion, and there is insufficient evidence to support clot dissolving therapy given into the artery or the vein for central occlusion2. Trials of early clot dissolving treatment are still running. The care with the clearest benefit is aimed at the source, to lower the chance that another fragment forms.
Usually these events hit one eye at a time, so the other is not typically in danger. The exception is inflammatory disease, where both eyes are at stake until treatment starts. In patients over 50, giant cell arteritis must be suspected, and urgent corticosteroid therapy is considered when it is diagnosed or very likely, partly to protect the other eye2. Once a week, cover one eye, then the other, and look at a straight line of text. Report any new gap the same day.
Because those questions screen for giant cell arteritis, an inflammation of medium and large arteries that can take the second eye quickly. It often announces itself through those symptoms rather than through vision. The Academy advises suspecting it in patients over 50 and considering urgent systemic corticosteroid therapy when it is diagnosed or very likely2. Blood tests usually support the diagnosis, though normal results do not rule it out. Answer those questions carefully, because they change what happens next.
Often yes, but that is a decision for your eye doctor and your local licensing rules, not for a web page. Sharpness is only part of it, since a missing wedge of field can matter more than the letters you read. Ask for formal visual field testing, ask how your result compares with your state or country standard, and ask when it should be repeated. If your job involves driving, ask for the result in writing.
Take this list in with you and write the answers down.
- Which type of occlusion do I have: central, branch, or a cilioretinal one?
- Which part of my visual field is affected, and can I have formal field testing?
- Have the tests for giant cell arteritis been done, and what did they show?
- Who is arranging my carotid imaging, echocardiogram and heart rhythm monitoring, and by when?
- Which of my blood pressure, cholesterol, blood sugar or rhythm medicines are changing because of this?
- Which symptoms should bring me back the same day rather than at my next visit?
- American Academy of Ophthalmology, EyeSmart patient education (2024). What Is a Retinal Artery Occlusion?.
- American Academy of Ophthalmology Preferred Practice Pattern (2024). Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern (2024).
- American Heart Association / Stroke (Mac Grory B, Schrag M, Biousse V, et al.) (2021). Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association (Top Things to Know).
- Ophthalmology (Hayreh SS, Podhajsky PA, Zimmerman MB), 199 consecutive untreated patients (212 eyes) seen 1973 to 2000 (2009). Branch retinal artery occlusion: natural history of visual outcome.
- StatPearls, NCBI Bookshelf (2023). Hollenhorst Plaque (StatPearls).
- BMC Ophthalmology (Park SH, Kim BJ, Kim JH, et al.), nationwide population-based study of 49,705,663 individuals (2024). Incidence rates of retinal vascular occlusive diseases from 2011 to 2020 in South Korea: a nationwide cohort study.
- Indian Journal of Ophthalmology (Hayreh SS), reporting the author's prospective Iowa series of 260 eyes in 244 consecutive patients plus the author's experimental primate studies (2018). Central retinal artery occlusion.
- Journal of Clinical Medicine (Roskal-Walek J, Laudanska-Olszewska I, Bilinski P, et al.), single-center cohort of 131 patients (94 central, 37 branch) diagnosed 2010 to 2020 and followed up to 11 years (2021). Central and Branch Retinal Artery Occlusion: Do They Harbor the Same Risk of Further Ischemic Events?.
- Eye (Lond) (Fallico M, Lotery AJ, Longo A, et al.) (2020). Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis.
- Journal of Neurology (Wang C, Chen X, Li Y, Zhu R, Feng J, Chen D, Chen T, Xiao X) (2025). Risks of stroke and myocardial infarction after retinal artery occlusion and their time dependence: a systematic review and meta-analysis.